Edition:
India

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

1,936.00DKK
7 Aug 2020
Change (% chg)

kr.68.00 (+3.64%)
Prev Close
kr.1,868.00
Open
kr.1,871.00
Day's High
kr.1,953.00
Day's Low
kr.1,868.00
Volume
23,008
Avg. Vol
18,169
52-wk High
kr.2,082.00
52-wk Low
kr.1,234.00

Summary

Name Age Since Current Position

Anders Hedegaard

58 2020 Chairman of the Board

Carsten Hellmann

55 2017 President, Chief Executive Officer

Lene Skole-Soerensen

60 2015 Vice Chairman of the Board

Soeren Jelert

48 2018 Chief Financial Officer, Executive Vice President

Soeren Niegel

49 Executive Vice President, Commercial Operations

Henrik Jacobi

55 Executive Vice President, Research & Development

Katja Barnkob

51 2011 Director, Employee Representative

Nanna Carlson

44 2019 Director, Employee Representative

Lars Holmqvist

61 2015 Director

Jakob Riis

53 2013 Director

Johan Smedsrud

48 2019 Director, Employee Representative

Vincent Warnery

52 2019 Director

Gonzalo De Miquel

53 2018 Independent Director

Per Plotnikof

Vice President Corporate Communications, Investor Relations and Strategic Planning

Biographies

Name Description

Anders Hedegaard

Mr. Anders Hedegaard has been appointed as Chairman of the Board of the Company, effective March 2020. He graduated in Chemistry and Molecular Biology from the Technical University of Denmark (DTU) in 1988. Since 1 February 2019, he has been CEO of German-based Rodenstock Group, a leading global manufacturer of ophthalmic lenses and spectacle frames, which has 4,900 employees, and sales offices and distribution partners in more than 85 countries. Anders Hedegaard has broad management experience from several listed life science and consumer care companies: 2014-19: CEO of GN Hearing A/S and GN Store Nord A/S. 2007-14: CEO of Bavarian Nordic A/S. 2002-07: Executive Vice President of Business Operations & International Marketing at ALK. Previously, he held senior positions at Novo Nordisk A/S and Foss A/S.

Carsten Hellmann

Mr. Carsten Hellmann serves as President, Chief Executive Officer of the Company. He has previously been CEO of Merial and Executive Vice President and member of the Executive Committee of Sanofi. Before joining Sanofi, Carsten Hellmann held executive positions in global health care and biopharmaceutical companies including Chr. Hansen and Nunc Group. He is Board Member at Coloplast A/S.

Lene Skole-Soerensen

Ms. Lene Skole serves as Vice Chairman of the Board of the Company. She is Member of the Audit, Scientific and Nomination Committee. She has been Member of the Board since March 12, 2014. She is Chief Executive Officer of The Lundbeck Foundation and holds directorships at two subsidiaries. She has experience, financial and economic knowledge and skills in strategy and communication in international companies. She is Vice Chairman of the Board of Oersted A/S, Falck A/S and H. Lundbeck A/S as well as Member of the Board of Tryg Forsikring A/S and Tryg A/S.

Soeren Jelert

Mr. Soeren Jelert serves as Chief Financial Officer, Executive Vice President of the Company. From 2008 until 2016, he was CFO at NNE, an engineering company that specializes in supporting pharmaceutical company engineering projects. Since 2016, he has been General Manager of NNE's US organization. His career has also included various finance roles at Novo Nordisk and Maersk.

Soeren Niegel

Mr. Soeren Daniel Niegel serves as Executive Vice President, Commercial Operations of the Company. He has Experience in management as well as global production and sales & marketing within the pharmaceutical industry.

Henrik Jacobi

Mr. Henrik Jacobi M.D. serves as Executive Vice President, Research & Development of the Company. He has Experience in management, innovation, and research & development in the pharmaceutical industry. Henrik Jacobi holds a degree in Medicine from 1993.

Katja Barnkob

Ms. Katja Barnkob serves as Director, Employee Representative of the Company. She serves as Senior CMC Project Manager at the Company. She has Experience in project management of global drug development projects in the pharmaceutical industry.

Nanna Carlson

Ms. Nanna Rassov Carlson serves as Director, Employee Representative of the Company. She is Expertise in production and release of ALK’s active pharmaceutical ingredients for SLIT products.

Lars Holmqvist

Mr. Lars Holmqvist serves as Director of the Company. He was previously Independent Member of the Board of Directors of ALK-Abello A/S from 2010 until March 12, 2013. He is also Member of the Company’s Remuneration Committee. Previously, he was Independent Vice Chairman of the Board of the Company between April 1, 2011 and March 27, 2012. Mr. Holmqvist is Member of the Board of BPL Holdings, UK; H. Lundbeck A/S; Tecan AG, Switzerland; Vitrolife AB and The Lundbeck Foundation. He has experience in management, finance, sales and marketing in international life science companies, including med-tech and pharmaceutical companies.

Jakob Riis

Mr. Jakob Riis serves as Director of the Company. He also serves as President and CEO of Falck A/S. He is Chairman of the Audit Committee at the Company. He has experience in management, sales and marketing in the international pharmaceutical industry. He is Chairman of Copenhagen Institute of Interaction Design and Board Member of Copenhagen Capacity and Falck Health Care Holding A/S.

Johan Smedsrud

Mr. Johan Smedsrud serves as Director, Employee Representative of the Company. He has Experience in HVAC systems, cleanroom testing, utensil washing and sterilisation for the pharmaceutical industry.

Vincent Warnery

Mr. Vincent Warnery serves as Director of the Company. He has Experience in management and sales & marketing in the international consumer healthcare industry.

Gonzalo De Miquel

Mr. Gonzalo De Miquel serves as Independent Director of the Company. He is Chairman of the Scientific Committee and Member of the Remuneration Committee. He is Chief Medical Officer and EVP of Development at Vectura Ltd. and Board Member of Ventaleon Ltd.

Per Plotnikof

Basic Compensation

Name Fiscal Year Total

Anders Hedegaard

--

Carsten Hellmann

14,204,000

Lene Skole-Soerensen

650,000

Soeren Jelert

6,568,000

Soeren Niegel

5,842,000

Henrik Jacobi

5,990,000

Katja Barnkob

275,000

Nanna Carlson

220,000

Lars Holmqvist

375,000

Jakob Riis

425,000

Johan Smedsrud

220,000

Vincent Warnery

220,000

Gonzalo De Miquel

525,000

Per Plotnikof

--
As Of  31 Dec 2019